ACTIVE

HuVePharma

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

5,9 M €

+23.3% YoY

Revenue

127,1 M €

+10.5% YoY

Equity

49,8 M €

+13.4% YoY

Workforce

102,2 ETP

+24.6% YoY

What does HuVePharma do?

HuVePharma is a Public limited company incorporated in 2005. Its main activity is: Wholesale of grain, unmanufactured tobacco, seeds and animal feeds. Its registered office is in Antwerpen. It employs on average 102,2 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0875.283.062

Incorporation

27/07/2005

Legal form

Public limited company

Registered office

Uitbreidingstraat 80
2600 Antwerpen · FlandreSee on map

Contributed capital

4 500 000,00 €

Latest accounts

31/12/2025

Average workforce

102,2 ETP

Activities (NACE)

46216Wholesale of grain, unmanufactured tobacco, seeds and animal feeds· main 46216Wholesale of grain, unmanufactured tobacco, seeds and animal feeds 46389Wholesale of other food, including fish, crustaceans and molluscs 46389Wholesale of other food, including fish, crustaceans and molluscs 51210Freight air transport 51384Air transport

Joint committees (1)

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 18 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2015		2014		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	127,1 M €	+10.5%	115 M €	+14.7%	100,3 M €	-0.4%	100,7 M €	+5.5%	95,5 M €	+3.6%	92,2 M €	+16.6%	79,1 M €	-0.9%	79,8 M €	+17.3%	68,1 M €	+52.5%	44,6 M €	+10.4%	40,4 M €	+40.8%	28,7 M €	+7.9%	26,6 M €	+8.5%	24,5 M €	+15.6%	21,2 M €	+36.1%	15,6 M €	-1.3%	15,8 M €	-14.6%	18,5 M €
EBITDA	21,5 M €	+13.7%	18,9 M €	+6.1%	17,8 M €	+0.2%	17,8 M €	+1.9%	17,5 M €	+10.2%	15,8 M €	+7.8%	14,7 M €	+13.7%	12,9 M €	+33.1%	9,7 M €	+98.3%	4,9 M €	+41.8%	3,5 M €	+129%	1,5 M €	+4.6%	1,4 M €	+8.3%	1,3 M €	+34.0%	992,5 k €	+1671%	-63,2 k €	+94.1%	-1,1 M €	+25.8%	-1,4 M €
Operating result	8,4 M €	+23.2%	6,8 M €	+8.7%	6,3 M €	-2.2%	6,4 M €	-1.4%	6,5 M €	+13.4%	5,8 M €	+11.6%	5,2 M €	-3.3%	5,3 M €	+23.7%	4,3 M €	+60.0%	2,7 M €	-2.5%	2,8 M €	+90.1%	1,5 M €	+6.3%	1,4 M €	+6.7%	1,3 M €	+42.3%	902,9 k €	+875%	-116,5 k €	+89.4%	-1,1 M €	+24.5%	-1,5 M €
Net result	5,9 M €	+23.3%	4,8 M €	+11.4%	4,3 M €	-1.2%	4,3 M €	-8.6%	4,8 M €	+11.8%	4,2 M €	+22.1%	3,5 M €	+10.7%	3,1 M €	+9.1%	2,9 M €	+115%	1,3 M €	-25.4%	1,8 M €	+95.1%	922,7 k €	-19.2%	1,1 M €	-14.2%	1,3 M €	+73.3%	767,8 k €	+993%	70,3 k €	+105%	-1,6 M €	+5.5%	-1,6 M €
Balance sheet
Equity	49,8 M €	+13.4%	43,9 M €	+12.2%	39,1 M €	+12.3%	34,8 M €	+14.2%	30,5 M €	+18.5%	25,7 M €	+19.8%	21,5 M €	+19.3%	18 M €	+21.2%	14,9 M €	+53.3%	9,7 M €	+16.1%	8,4 M €	+51.1%	5,5 M €	+20.0%	4,6 M €	+33.0%	3,5 M €	+62.4%	2,1 M €	+56.3%	1,4 M €	+5.4%	1,3 M €	-54.6%	2,9 M €
Total assets	107,7 M €	+10.4%	97,5 M €	+18.0%	82,7 M €	+1.9%	81,1 M €	+2.0%	79,5 M €	+2.0%	78 M €	+10.3%	70,7 M €	+9.3%	64,7 M €	+4.2%	62,1 M €	+59.7%	38,9 M €	+22.1%	31,8 M €	+102%	15,7 M €	+28.8%	12,2 M €	+15.1%	10,6 M €	-5.5%	11,2 M €	+30.9%	8,6 M €	-18.3%	10,5 M €	+38.7%	7,6 M €
Cash	4,6 M €	-20.8%	5,8 M €	+33.1%	4,4 M €	-6.4%	4,7 M €	+19.7%	3,9 M €	+40.2%	2,8 M €	+76.6%	1,6 M €	+6.1%	1,5 M €	+5.7%	1,4 M €	-47.8%	2,7 M €	+30.7%	2,1 M €	+218%	646,8 k €	+132%	278,6 k €	-43.9%	496,6 k €	+33.2%	372,9 k €	+35.7%	274,8 k €	-28.6%	385,1 k €	+38.4%	278,3 k €
Debts	50,5 M €	+4.8%	48,2 M €	+26.5%	38,1 M €	-7.7%	41,3 M €	-9.3%	45,6 M €	-6.2%	48,6 M €	+7.5%	45,2 M €	+4.4%	43,3 M €	-2.8%	44,5 M €	+69.2%	26,3 M €	+27.5%	20,6 M €	+141%	8,6 M €	+31.2%	6,5 M €	+4.6%	6,2 M €	-26.3%	8,5 M €	+32.7%	6,4 M €	-27.0%	8,7 M €	+96.7%	4,4 M €
Other
Workforce	102,2 ETP	+24.6%	82,0 ETP	+1.2%	81,0 ETP	+2.1%	79,3 ETP	+4.2%	76,1 ETP	+5.8%	71,9 ETP	+11.6%	64,4 ETP	+21.1%	53,2 ETP	-2.9%	54,8 ETP	+38.0%	39,7 ETP	-25.1%	53,0 ETP	+28.6%	41,2 ETP	+17.0%	35,2 ETP	+28.5%	27,4 ETP	+12.8%	24,3 ETP	+6.6%	22,8 ETP	+29.5%	17,6 ETP	+61.5%	10,9 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 15 ended

Active mandates

SDL Management

Director · since 16 mai 2024 · until 16 mai 2030 · 1004.519.033

Represented by Sven Verbraeken

Active

Eddy PIRON

Managing director · since 18 mai 2017 · until 17 mai 2029

Active

Kiril DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 17 mai 2029

Active

Ended mandates

Sven VERBRAEKEN

Director · since 21 mai 2020 · until 21 mai 2026

Ended

Eddy PIRON

Managing director · since 18 mai 2017 · until 18 mai 2023

Ended

Kiril DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 18 mai 2023

Ended

Kirirl DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 18 mai 2023

Ended

At this address

Other companies at this address

Company	CBE no.
Multiservice FINANCE● Bankrupt	0879.561.554
TriFinance Belgium● Active	0882.734.939

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	19/06/2026	14/06/2025	24/06/2024	05/06/2023	21/06/2022	22/10/2021
General meeting	21/05/2026	15/05/2025	16/05/2024	19/05/2023	19/05/2022	28/09/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

32 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	21/05/2026	19/06/2026	Dutch	PDF
Full model	31/12/2024	15/05/2025	14/06/2025	Dutch	PDF
Consolidated accounts	31/12/2024	15/05/2025	14/06/2025	Dutch	PDF
Full model	31/12/2023	16/05/2024	24/06/2024	Dutch	PDF
Consolidated accounts	31/12/2023	16/05/2024	24/06/2024	Dutch	PDF
Full model	31/12/2022	19/05/2023	05/06/2023	Dutch	PDF
Consolidated accounts	31/12/2022	19/05/2023	05/06/2023	Dutch	PDF
Full model	31/12/2021	19/05/2022	21/06/2022	Dutch	PDF
Consolidated accounts	31/12/2021	19/05/2022	21/06/2022	Dutch	PDF
Full modelCorrection	31/12/2020	28/09/2021	22/10/2021	Dutch	PDF
Full model	31/12/2020	20/05/2021	28/05/2021	Dutch	PDF
Consolidated accounts	31/12/2020	20/05/2021	27/05/2021	Dutch	PDF
Full model	31/12/2019	21/05/2020	17/06/2020	Dutch	PDF
Consolidated accounts	31/12/2019	21/05/2020	17/06/2020	Dutch	PDF
Full model	31/12/2018	16/05/2019	23/06/2019	Dutch	PDF
Consolidated accounts	31/12/2018	16/05/2019	23/06/2019	Dutch	PDF
Full model	31/12/2017	17/05/2018	18/06/2018	Dutch	PDF
Consolidated accounts	31/12/2017	17/05/2018	18/06/2018	Dutch	PDF
Full model	31/12/2016	18/05/2017	28/06/2017	Dutch	PDF
Consolidated accounts	31/12/2016	18/05/2017	30/06/2017	Dutch	PDF
Full model	31/12/2015	19/05/2016	28/06/2016	Dutch	PDF
Consolidated accounts	31/12/2015	19/05/2016	22/07/2016	Dutch	PDF
Full model	31/12/2014	21/05/2015	29/06/2015	Dutch	PDF
Consolidated accounts	31/12/2014	21/05/2015	28/07/2015	Dutch	PDF

View all 32 filings

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 3 active · 15 ended

Active mandates

SDL Management

Director · since 16 mai 2024 · until 16 mai 2030 · 1004.519.033

Represented by Sven Verbraeken

Active

Eddy PIRON

Managing director · since 18 mai 2017 · until 17 mai 2029

Active

Kiril DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 17 mai 2029

Active

Ended mandates

Sven VERBRAEKEN

Director · since 21 mai 2020 · until 21 mai 2026

Ended

Eddy PIRON

Managing director · since 18 mai 2017 · until 18 mai 2023

Ended

Kiril DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 18 mai 2023

Ended

Kirirl DOMUSCHIEV

Chairman of the board of directors · since 18 mai 2017 · until 18 mai 2023

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates27/08/2026
Ontslag - (her)benoeming (gedelegeerd) bestuurder(s)
PDF
Mandates21/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other07/12/2023
DIVERSEN
PDF
Mandates03/07/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/09/2021
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/05/2021
ONTSLAGEN - BENOEMINGEN
PDF
Other06/12/2019
DIVERSEN
PDF
Mandates27/08/2018
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20255,9 M €↑
2024
Annual accounts 20244,8 M €↑
16/05/2024
reconductionBDO Bedrijfsrevisoren — commissaris
16/05/2024
nominationDavid Lenaerts — vaste vertegenwoordiger
16/05/2024
nominationSDE Management — bestuurder
16/05/2024
nominationSven Verbraeken — vaste vertegenwoordiger
2023
Annual accounts 20234,3 M €↓
19/05/2023
reconductionKiril Domuschiev — bestuurder
19/05/2023
reconductionEddy Piron — bestuurder
2022
Annual accounts 20224,3 M €↓
2021
Annual accounts 20214,8 M €↑
2020
Annual accounts 20204,2 M €↑
2019
Annual accounts 20193,5 M €↑
2018
Annual accounts 20183,1 M €↑
2017
Annual accounts 20172,9 M €↑
2015
Annual accounts 20151,3 M €↓
2014
Annual accounts 20141,8 M €↑
2012
Annual accounts 2012922,7 k €↓
2011
Annual accounts 20111,1 M €↓
2010
Annual accounts 20101,3 M €↑
2009
Annual accounts 2009767,8 k €↑
2008
Annual accounts 200870,3 k €↑
2007
Annual accounts 2007-1,6 M €↑
2006
Annual accounts 2006-1,6 M €
27/07/2005
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

HuVePharma

Overview

What does HuVePharma do?

Trend over 18 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline